has been cited by the following article(s):
[1]
|
An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition
Drug Discovery Today,
2022
DOI:10.1016/j.drudis.2022.01.011
|
|
|
[2]
|
An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition
Drug Discovery Today,
2022
DOI:10.1016/j.drudis.2022.01.011
|
|
|